Larimar Therapeutics, Inc. (LRMR) - Latest Market Data

Price & Market Data

Price: $2.77

Daily Change: -$0.14 / 5.05%

Range: $2.75 - $3.02

Market Cap: $184,400,352

Volume: 900,865

Performance Metrics

1 Week: 7.46%

1 Month: 60.89%

3 Months: 11.20%

6 Months: -56.16%

1 Year: -69.16%

YTD: -25.58%

Company Details

Employees: 65

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Selected stocks

Seritage Growth Properties (SRG)

NeoVolta Inc. (NEOV)

Solidion Technology, Inc. (STI)